Santoyo-Sánchez A, Ramos-Peñafiel CO, Saavedra-González A, González-Almanza L, Martínez-Tovar A, Olarte-Carrillo I, Collazo-Jaloma J

Language: Spanish
References: 24
Page: 208-212
PDF size: 137.52 Kb.

ABSTRACT

Introduction: A lack of a population-based cancer registry or underreporting is common in developing countries, without knowledge of the true dimensions of the problem. Aim: To describe the age and sex frequencies of the major subtypes of leukemias in two reference hospitals in the metropolitan area of Mexico City. Material and methods: A descriptive and retrospective study, based on medical records of two hematology services during January 2007 to October 2014; all cases diagnosed with leukemia were included. Results: A total of 1,432 cases were included, with a median age of 38 years old (2 months to 115 years). There were significant age differences between subtypes of leukemia (ANOVA test, p = 0.000); chronic lymphocytic with a mean age of 64.8 years, higher than chronic myeloid (43.4 years) and all acute leukemias (lymphoblastic: 32.6 years, myeloblastic 43.5 years). Of the patients, 51.8% (n = 742) were women, although males predominated in chronic myeloid (57.8%) and lymphocytic (60%) leukemia. Acute lymphoblastic leukemia was the more common variety L2 subtype of the French-American-British classification, followed by myeloid leukemia M4, M2, and chronic myeloid. Conclusions: it is necessary to develop inter-institutional works in order to group data of different population sectors and improve the epidemiological profile of leukemias in Mexico.

REFERENCES

1. Hurtado-Monroy R, Solano-Estrada B, Vargas-Viveros P. Leucemia para el médico general. Rev Fac Med UNAM. 2012;55(2):11-25.

2. Tirado-Gómez LL, Mohar-Betancourt A. Epidemiología de las neoplasias hemato-oncológicas. Rev Inst Nac Cancerol. 2007;2:109-20.

3. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012;119(1):34-43.

4. Satram-Hoang S, Reyes C, Hoang KQ, Momin F, Skettino S. Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database. Ann Hematol. 2014;93(8):1335-44.

5. Woyach JA, Ruppert AS, Rai K, et al. Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies. J Clin Oncol. 2013;31(4): 440-7.

6. Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724-34.

7. Ramírez-Duarte S, Santoyo-Sánchez A, Collazo-Jaloma J, et al. Correlación entre la edad y la cifra de leucocitos al diagnóstico de leucemia aguda. Rev Hematol Mex. 2013;14:9-14.

8. Ganzel C, Rowe JM. Prognostic factors in adult acute leukemia. Hematol Oncol Clin North Am. 2011;25(6):1163-87.

9. Hamouda F, El-Sissy A. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukaemia; experience at the national cancer institute, Cairo university, Egypt. J Egypt Nat Cancer Inst. 2007;19(2):87-95.

10. Santoyo-Sánchez A, Ramos-Peñafiel C, Palmeros-Morgado G, et al. [Clinical features of acute leukemia and its relationship to the season of the year]. Rev Med Inst Mex Seguro Soc. 2014;52(2):176-81.

11. Mejía-Aranguré JM, Fajardo-Gutiérrez A, Bernáldez-Ríos R, Paredes- Aguilera R, Flores-Aguilar H, Martínez-García MC. [Incidence of acute leukemia in children in Mexico City, from 1982 to 1991]. Salud Publica Mex. 2000;42(5):431-437.

12. Mejía-Aranguré JM, Bonilla M, Lorenzana R, et al. Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000: population-based data. BMC Cancer. 2005;5(1):33.

13. Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11(1):355.

14. Mohar A, Frías M, Suchil L, Mora T, de la Garza JG. [Descriptive epidemiology cancer in the National Cancer Institute of Mexico]. Salud Publica Mex. 1997;39(4):253-8.

15. Fernández-Canton SB, León-Álvarez G, Herrera-Torres M del C, et al. Perfil epidemiológico de los tumores malignos en México. Ciudad de México: Secretaría de Salud; 2011.

16. Allende-López A, Fajardo-Gutiérrez A. [History of the cancer registry in Mexico]. Rev Med Inst Mex Seguro Soc. 2011;49 Suppl 1:S27-32.

17. Athié-Gutiérrez C. Reporte de gestión de las actividades realizadas del 1.o de enero al 30 de septiembre de 2014 y asuntos relevantes del Hospital General de México Dr. Eduardo Liceaga. 2014. p. 83. [Internet] Consultado el 2 de enero de 2015. Disponible en: http://www.hgm.salud. gob.mx/descargas/pdf/dirgral/informes_junta/info_ene_sep_14.pdf

18. González-Salas WM, Olarte-Carrillo I, Gutiérrez-Romero M, Montaño- Figueroa EH, Martínez-Murillo C, Ramos-Peñafiel CO. [Acute leukemia frequency observed in a reference hospital]. Rev Med Inst Mex Seguro Soc. 2012;50(2):167-71.

19. Buitrón-Santiago N, Arteaga-Ortiz L, Rosas-López A, Aguayo A, López-Karpovitch X, Crespo-Solís E. [Acute myeloid leukemia in adults: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán from 2003 to 2008]. Rev Invest Clin. 2010;62(2):100-8.

20. Gutiérrez JP, Hernández-Ávila M. [Health protection coverage in Mexico, and profile of unprotected population 2000-2012]. Salud Publica Mex. 2013;55 Suppl 2:S83-S90.

21. Gutiérrez JP, García-Saisó S, Dolci GF, Hernández Ávila M. Effective access to health care in Mexico. BMC Health Serv Res. 2014;14:186.

22. Estey EH. Acute myeloid leukemia: 2014 update on risk-stratification and management. Am J Hematol. 2014;89(11):1063-81.

23. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107(9):3481-5.

24. Catovsky D, Wade R, Else M. The clinical significance of patients’ sex in chronic lymphocytic leukemia. Haematologica. 2014;99(6):1088-94.